The first study assessing weight-loss drugs reveals significant benefits for heart health and mental well-being but also warns of potential digestive and pancreatic risks.
Lead researcher Dr. Ziyad al-Aly emphasizes that while weight-loss drugs like Ozempic and Wegovy have transformative potential, careful interpretation of their wide-ranging health impacts is essential.
Collection
[
|
...
]